Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Apatinib Combined”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04569916
What this trial is testing

Radiotherapy Combined With Irinotecan and Apatinib Followed by PD-1 Antibody and Apatinib for Advanced Solid Tumors

Who this might be right for
Solid Tumor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06592287
What this trial is testing

The Combination of Adebrelimab, Apatinib, and Lrinotecan Liposome for Second-line Treatment of Advanced Gastric Cancer

Who this might be right for
Advanced Gastric Cancer
Xianglin Yuan 66
Not applicableUnknownNCT04950400
What this trial is testing

Camrelizumab Combined With Chemotherapy Sequential Camrelizumab Combined With Apatinib Treatment of Advanced NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Beijing Chest Hospital 60
Not applicableUnknownNCT05380986
What this trial is testing

Camrelizumab Combined With Apatinib Mesylate

Who this might be right for
Solid Tumor
Henan Cancer Hospital 500
Testing effectiveness (Phase 2)Looking for participantsNCT06792162
What this trial is testing

PD-1 Antibody Carilizumab Combined with Apatinib for Unresectable Stage III and IV DMMR Gastric Cancer

Who this might be right for
Gastric Cancer
Peking University Third Hospital 20
Large-scale testing (Phase 3)Active Not RecruitingNCT04521153
What this trial is testing

Camrelizumab Combined With Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaImmunotherapyMolecular Targeted Therapy
Shanghai Zhongshan Hospital 294
Testing effectiveness (Phase 2)UnknownNCT04878107
What this trial is testing

SBRT/LDRT in Combination With Camrelizumab and Apatinib in Metastatic Non-small Cell Lung Cancer Patient Previously Treated With PD-1/L1 Inhibitor and Chemotherapy

Who this might be right for
Non-Small Cell Lung Cancer
Wuhan University 88
Testing effectiveness (Phase 2)Study completedNCT03547804
What this trial is testing

A Prospective, Single-center, One-arm Clinical Study of Apatinib Combined With Chemotherapy for Pretreated Patients With Advanced Small Cell Lung Cancer

Who this might be right for
Small-cell Lung Cancer
The First Hospital of Jilin University 31
Early research (Phase 1)Study completedNCT03945604
What this trial is testing

A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Apatinib and Fluzoparib in Patients With TNBC

Who this might be right for
Triple Negative Breast Cancer
Jiangsu HengRui Medicine Co., Ltd. 32
Testing effectiveness (Phase 2)UnknownNCT04204577
What this trial is testing

The Safety and Efficacy of Thermal Ablation Combined With Apatinib and Carilimub for Advanced Liver Cancer

Who this might be right for
BCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular Carcinoma
Chinese PLA General Hospital 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07324473
What this trial is testing

Ivarmacitinib Combined With Camrelizumab and Apatinib for Unresectable Advanced Hepatocellular Carcinoma With Acquired Resistance to Immune Checkpoint Therapy: A Single-Arm Exploratory Clinical Study

Who this might be right for
Hepatocellular CarcinomasResistance to ImmunotherapyImmunomodulation+1 more
First Affiliated Hospital of Chongqing Medical University 65
Testing effectiveness (Phase 2)UnknownNCT04126993
What this trial is testing

Study of SHR-1210 Combined With Apatinib in the Treatment of Sarcoma

Who this might be right for
Sarcoma
Tianjin Medical University Cancer Institute and Hospital 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT06693128
What this trial is testing

Camrelizumab Combined With or Without Apatinib and SOX of Neoadjuvant Treatment for Gastric Cancer

Who this might be right for
Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
Ruijin Hospital 80
Testing effectiveness (Phase 2)Study completedNCT04047017
What this trial is testing

Camrelizumab Combined With Apatinib for Recurrent Resistant GTN

Who this might be right for
Gestational Trophoblastic Disease
Peking Union Medical College Hospital 20
Testing effectiveness (Phase 2)UnknownNCT03007446
What this trial is testing

The Study of Conversion Surgery for Apatinib in Combination With SOX for Patients With Unresectable Gastric Cancer

Who this might be right for
Gastric Cancer
Chinese PLA General Hospital 20
Testing effectiveness (Phase 2)UnknownNCT03932526
What this trial is testing

Combined Use of Apatinib Mesylate and Vinorelbine Versus Single Use of Vinorelbine in Triple-negative Breast Cancer

Who this might be right for
Triple-negative Breast Cancer
Liaoning Cancer Hospital & Institute 184
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06538935
What this trial is testing

SBRT Combined With Adbelimumab and Apatinib for Perioperative and Conversion Therapy of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaSBRTImmune Checkpoint Blockade+1 more
Fujian Cancer Hospital 80
Large-scale testing (Phase 3)UnknownNCT04490421
What this trial is testing

Camrelizumab Combined With Apatinib, Etoposide and Cisplatin Treat Small-cell Lung Cancer.

Who this might be right for
Lung NeoplasmSmall Cell Lung CancerPD-1 Inhibitors
Fuzhou General Hospital 45
Testing effectiveness (Phase 2)UnknownNCT04126811
What this trial is testing

Apatinib Combined With Chemotherapy in the Treatment of Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Tianjin Medical University Cancer Institute and Hospital 120
Testing effectiveness (Phase 2)UnknownNCT04267549
What this trial is testing

Conversion Therapy of Sintilimab in Combination With Apatinib and Chemotherapy in Stage IV Gastric Cancer

Who this might be right for
Gastric Cancer Stage IV
Tianjin Medical University Cancer Institute and Hospital 47
Next Page